InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.71
(
0.50%
)
Bitcoin
58,689.36
(
2.37%
)
Post# of 116087
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

valuemind

Send PM Follow Ignore
Followers 40
Posts 1690
Boards Moderated 0
Alias Born 01/21/2005

valuemind

Re: researcher59 post# 110341

Thursday, 02/01/2024 4:01:38 AM

Thursday, February 01, 2024 4:01:38 AM

Post# of 116087
Even if GERN’s blood cancer drug has got approved today, ARDX maybe better buy, because ARDX’s two already approved and fast selling drugs had market potential at peak 3 times GERN's, and its stock market capitalization is only 2 times GERN's.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up